HK1203822A1 - Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers --- - Google Patents
Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers ---Info
- Publication number
- HK1203822A1 HK1203822A1 HK15104314.4A HK15104314A HK1203822A1 HK 1203822 A1 HK1203822 A1 HK 1203822A1 HK 15104314 A HK15104314 A HK 15104314A HK 1203822 A1 HK1203822 A1 HK 1203822A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- beta
- methylbutyrate
- glutamine
- arginine
- hydroxy
- Prior art date
Links
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 title 1
- 239000004475 Arginine Substances 0.000 title 1
- 206010056340 Diabetic ulcer Diseases 0.000 title 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261585265P | 2012-01-11 | 2012-01-11 | |
| PCT/US2013/021029 WO2013106570A1 (en) | 2012-01-11 | 2013-01-10 | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1203822A1 true HK1203822A1 (en) | 2015-11-06 |
Family
ID=47561872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15104314.4A HK1203822A1 (en) | 2012-01-11 | 2015-05-06 | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers --- |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10064835B2 (xx) |
| EP (1) | EP2802322B1 (xx) |
| JP (2) | JP2015503619A (xx) |
| CN (1) | CN104302285A (xx) |
| BR (1) | BR112014016950A8 (xx) |
| CA (1) | CA2860642C (xx) |
| ES (1) | ES2668885T3 (xx) |
| HK (1) | HK1203822A1 (xx) |
| MX (1) | MX2014008521A (xx) |
| PH (1) | PH12014501579A1 (xx) |
| SG (1) | SG11201403951UA (xx) |
| TW (1) | TWI592153B (xx) |
| WO (1) | WO2013106570A1 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2860642C (en) | 2012-01-11 | 2016-11-01 | Abbott Laboratories | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers |
| DE102018124227A1 (de) | 2018-10-01 | 2020-04-02 | sanaFactur GmbH | Zubereitung zur Verbesserung körpereigener Wundheilung |
| WO2022177516A1 (en) * | 2021-02-17 | 2022-08-25 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Nutritional powder compositions for promoting wound healing |
| WO2022225779A1 (en) | 2021-04-19 | 2022-10-27 | Abbott Laboratories | Methods and compositions for promoting wound healing |
| WO2023027859A1 (en) * | 2021-08-26 | 2023-03-02 | Abbott Laboratories | Methods and compositions for improving wound healing |
| CN115067518A (zh) * | 2022-06-07 | 2022-09-20 | 广东特芯生物科技有限公司 | 一种用于提高肿瘤患者免疫力的组合物 |
| CN115040550A (zh) * | 2022-06-07 | 2022-09-13 | 广东特芯生物科技有限公司 | 一种用于提高免疫球蛋白g的组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6031000A (en) | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| CA2860642C (en) | 2012-01-11 | 2016-11-01 | Abbott Laboratories | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers |
-
2013
- 2013-01-10 CA CA2860642A patent/CA2860642C/en active Active
- 2013-01-10 EP EP13700442.0A patent/EP2802322B1/en active Active
- 2013-01-10 JP JP2014552301A patent/JP2015503619A/ja active Pending
- 2013-01-10 MX MX2014008521A patent/MX2014008521A/es unknown
- 2013-01-10 WO PCT/US2013/021029 patent/WO2013106570A1/en active Application Filing
- 2013-01-10 US US14/371,905 patent/US10064835B2/en active Active
- 2013-01-10 SG SG11201403951UA patent/SG11201403951UA/en unknown
- 2013-01-10 CN CN201380012701.0A patent/CN104302285A/zh active Pending
- 2013-01-10 ES ES13700442.0T patent/ES2668885T3/es active Active
- 2013-01-10 BR BR112014016950A patent/BR112014016950A8/pt not_active IP Right Cessation
- 2013-01-11 TW TW102101221A patent/TWI592153B/zh active
-
2014
- 2014-07-09 PH PH12014501579A patent/PH12014501579A1/en unknown
-
2015
- 2015-05-06 HK HK15104314.4A patent/HK1203822A1/xx unknown
-
2017
- 2017-11-20 JP JP2017222466A patent/JP2018076320A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2802322A1 (en) | 2014-11-19 |
| US20150133548A1 (en) | 2015-05-14 |
| SG11201403951UA (en) | 2014-08-28 |
| TW201334774A (zh) | 2013-09-01 |
| CA2860642C (en) | 2016-11-01 |
| EP2802322B1 (en) | 2018-02-28 |
| JP2018076320A (ja) | 2018-05-17 |
| BR112014016950A2 (pt) | 2017-06-13 |
| CA2860642A1 (en) | 2013-07-18 |
| TWI592153B (zh) | 2017-07-21 |
| CN104302285A (zh) | 2015-01-21 |
| PH12014501579A1 (en) | 2014-10-08 |
| MX2014008521A (es) | 2014-08-21 |
| US10064835B2 (en) | 2018-09-04 |
| ES2668885T3 (es) | 2018-05-22 |
| WO2013106570A1 (en) | 2013-07-18 |
| BR112014016950A8 (pt) | 2017-07-04 |
| JP2015503619A (ja) | 2015-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273194B (en) | Methods, compounds and preparations for the treatment of parainfluenza virus in patients with a deficiency in the immune system | |
| HK1251796A1 (zh) | 治療糖尿病的方法和組合物 | |
| HK1214521A1 (zh) | 用於治療蛋白質病的組合物和方法 | |
| HK1205172A1 (en) | Polymer, process and composition | |
| AP2015008355A0 (en) | 5-Phenoxy-3H-pyrimidin-4-one diravatives and theiruse as hiv reverse transcriptase inhibitors | |
| HK1203822A1 (en) | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers --- | |
| HK1209633A1 (en) | Compositions and methods for treating diabetes | |
| HK1205150A1 (en) | Methods of treatment with arginine deiminase | |
| HK1214274A1 (zh) | 用於治療肝臟疾病和心血管疾病的脂肽 | |
| EP2867239A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES | |
| PL3326642T3 (pl) | Długo działające czynniki krzepnięcia i ich zastosowania | |
| EP2877214A4 (en) | PREDICTION AND TREATMENT OF DIABETIC COMPLICATIONS | |
| HK1214355A1 (zh) | 用於治療和/或限制糖尿病發展的方法 | |
| HK1208598A1 (en) | Methods and compositions for treating pain | |
| PL2852953T3 (pl) | Miejscowa koncentracja energii | |
| EP2807256A4 (en) | MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE | |
| ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
| EP2800568A4 (en) | COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR | |
| GB201213782D0 (en) | Process and dressing | |
| HK1214267A1 (zh) | 組合物和改善葡萄糖攝取的方法 | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| HK1207561A1 (en) | Compositions and methods for treating hepatocellular cancer | |
| LT2863931T (lt) | Kompozicijos, skirtos panaudoti žaizdų gydymui | |
| HK1207154A1 (en) | C1q-adiponectin complex and use thereof c1q- | |
| GB201222736D0 (en) | Composition and process |